Order Article Reprints

Martino M, Gori M, Porto G, Policastro G, Pitea M, Sgarlata A, Delfino IM, Cogliandro F, Scopelliti A, Utano G, et al. First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study. Cancers. 2024; 16(19):3307. https://doi.org/10.3390/cancers16193307

Martino, Massimo, Mercedes Gori, Gaetana Porto, Giorgia Policastro, Martina Pitea, Annalisa Sgarlata, Ilaria Maria Delfino, Francesca Cogliandro, Anna Scopelliti, Giovanna Utano, and et al. 2024. "First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study" Cancers 16, no. 19: 3307. https://doi.org/10.3390/cancers16193307

Martino, M., Gori, M., Porto, G., Policastro, G., Pitea, M., Sgarlata, A., Delfino, I. M., Cogliandro, F., Scopelliti, A., Utano, G., Pellicano, M., Idato, A., Vincelli, I. D., Marafioti, V., Micò, M. C., Lazzaro, G., Loteta, B., Alati, C., Leanza, G., ... Pitino, A. (2024). First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study. Cancers, 16(19), 3307. https://doi.org/10.3390/cancers16193307